Akero Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)

Akero Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)

Akero Therapeutics, Inc. reported Diluted Shares Outstanding (Weighted Average) of 82.01 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-11-07

• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 82.01M shares, a 18.10% increase year-over-year.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 81.72M shares, a 18.16% increase year-over-year.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 78.66M shares, a 32.62% increase year-over-year.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 70.60M shares, a 26.63% increase year-over-year.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 67.14M shares, a 27.71% increase from fiscal 2023.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 52.57M shares, a 34.84% increase from fiscal 2022.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 38.98M shares, a 11.94% increase from fiscal 2021.
• Akero Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 34.83M shares, a 10.69% increase from fiscal 2020.